Patent · US Active

Manufacturing process for pyrimidine derivatives

US9452994B2 · kind B2 · utility

0Cited by

0References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Dietmar Flubacher · Glückstadt, DE
Pascal Michel · Rheinfelden, CH
Maria Caterina Testa · Basel, CH
Rasmus Mose · Hobro, DK

Key dates

Filing date	May 6, 2016
Grant date	Sep 27, 2016
Priority date	—
Expiry date	May 6, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F5/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to processes for manufacturing a compound of formula 5,or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of such solid forms for the therapeutic treatment of warm-blooded animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.